Table 7.

Triplet mismatch subgroups and CCIs



CCIs when HIMMs ≤ 3

CCIs when HIMMs > 3

p2 value ≤3 vs > 3

CCIs when total MM ≤ 9

CCIs when total MM > 9

p2 value ≤ 9 vs > 9

No.
Median
No.
Median
No.
Median
No.
Median
All transfusions   184   14.0 (10-19)   339   11.2 (6-16)   < .001   216   13.5 (10-18)   307   11.2 (6-16)   < .001  
CREG-compatible transfusions   112   14.1 (10-20)   58   8.5 (4-14)   < .001   120   13.2 (9-20)   50   10.6 (4-15)   < .001  
CREG-incompatible transfusions
 
72
 
13.8 (10-17)
 
281
 
11.7 (6-16)
 
.010
 
96
 
13.6 (10-17)
 
257
 
11.2 (6-17)
 
.029
 


CCIs when HIMMs ≤ 3

CCIs when HIMMs > 3

p2 value ≤3 vs > 3

CCIs when total MM ≤ 9

CCIs when total MM > 9

p2 value ≤ 9 vs > 9

No.
Median
No.
Median
No.
Median
No.
Median
All transfusions   184   14.0 (10-19)   339   11.2 (6-16)   < .001   216   13.5 (10-18)   307   11.2 (6-16)   < .001  
CREG-compatible transfusions   112   14.1 (10-20)   58   8.5 (4-14)   < .001   120   13.2 (9-20)   50   10.6 (4-15)   < .001  
CREG-incompatible transfusions
 
72
 
13.8 (10-17)
 
281
 
11.7 (6-16)
 
.010
 
96
 
13.6 (10-17)
 
257
 
11.2 (6-17)
 
.029
 

HLAMatchmaker carried out HLA-A and -B compatibility determinations at triplet level and identified the number of highly immunogenic and total triplet mismatches for each donor-patient combination. Transfusions were sorted into subgroups based on the number of mismatches (≤ 3 and > 3 HIMMs; ≤ 9 and > 9 TMMs). The median CCIs for each group was determined, and comparisons between groups were done using the Student t test. The median number of HIMMs and TMMs are presented with the first and third quartile values (in parentheses). The 2 cohorts were compared using unpaired, 2-tailed Student t test.

or Create an Account

Close Modal
Close Modal